Evidence map›Paper›PMID 33236176›Full record

ArticleMolecular diversity2021

Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.

Neelutpal Gogoi, Purvita Chowdhury, Ashis Kumar Goswami, Aparoop Das, Dipak Chetia, Bhaskarjyoti Gogoi

Open access · bronzeAbstract read
In one paragraph

Article in Molecular diversity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. In Silico Design of New Dual Inhibitors of SARS-CoV-2 MInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Bioavailability and Safety of Dihydroquercetin (Review).Pharmaceutical chemistry journal · 2022
    Article
  16. Oxidative Stress-Related Mechanisms in SARS-CoV-2 Infections.Oxidative medicine and cellular longevity · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Neelutpal GogoiDepartment of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, India.
Purvita ChowdhuryDepartment of Health Research, Model Rural Health Research Unit, Tripura, 799035, India.
Ashis Kumar GoswamiDepartment of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, India.
Aparoop DasDepartment of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, India.
Dipak ChetiaDepartment of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, 786004, India.
Bhaskarjyoti GogoiDepartment of Biotechnology, Royal School of Bio-Science, Royal Global University, Guwahati, 781035, India. gogoi.bhaskar2608@gmail.com.
Dibrugarh University · INDepartment of Health Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although vaccine development is being undertaken at a breakneck speed, there is currently no effective antiviral drug for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19. Therefore, the present study aims to explore the possibilities offered by naturally available and abundant flavonoid compounds, as a prospective antiviral drug to combat the virus. A library of 44 citrus flavonoids was screened against the highly conserved Main Protease (M

Indexed as

Drug DiscoveryCitrusCoronavirus 3C ProteasesFlavonoidsMolecular Docking SimulationProtease InhibitorsProtein ConformationQuercetinSARS-CoV-2Coronavirus 3C ProteasesFlavonoidsProtease InhibitorsQuercetintaxifolinCOVID-19FlavonoidsMain proteaseMolecular dockingMolecular dynamicSARS-CoV-2

Identifiers

PMID33236176
PMCPMC7685905
OpenAlexW3108127937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.